In a prospective study, the routine handling of psychotropic drugs in five nursing homes in Bergen, Norway, was examined in patients who were admitted to a permanent stay. A follow-up was performed after 3 months. Of the 83 patients who were admitted 64% consumed psychotropic drugs, at follow-up 68%
Nursing home structure and association with agitation and use of psychotropic drugs in nursing home residents in three countries: Norway, Austria and England
β Scribed by I. Testad; S. Auer; M. Mittelman; C. Ballard; J. Fossey; Y. Donabauer; D. Aarsland
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 120 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0885-6230
- DOI
- 10.1002/gps.2414
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Background
Understanding the underlying mechanisms and risk factors leading to agitation is crucial to reduce the severity of agitation and increase quality of life. International comparative studies offer special advantages in elucidating environmental risk factors by providing a wider diversity of environmental exposures such as nursing home structures, health care systems and genetic diversity.
Methods
Baseline data for three different intervention studies in Austria (nβ=β38), England (nβ=β302) and Norway (nβ=β163) were combined posthoc. Patients were grouped according to their dementia severity using the global deterioration scale (GDS), functional assessment staging (FAST) and clinical dementia rating (CDR) scales. For the measurement of agitation, the CohenβMansfield Agitation Inventory (CMAI) was used. Data analysis was performed using oneβway ANOVA, multivariate and linear regression analysis.
Results
CMAI scores were available for 503 subjects with dementia. There were significant differences between the nursing home residents in the three countries regarding age, gender and dementia severity (all p valuesβ<β0.001). In the multivariate analyses, the level of agitation differed with higher mean scores in the Austrian (mean (SD) score 51.9(21.8)) compared to UK (43.3(16.1)) and Norwegian (41.6(13.2)) nursing homes (pβ=β0.002). Similarly, the use of psychotropic drugs differed significantly, with a higher proportion of neuroleptics in UK (48%, pβ<β0.001) and Austrian (52.6%; pβ=β0.001) compared to Norwegian (19%) nursing homes.
Conclusion
We found differences in agitation and antipsychotic drug use which are likely related to structural and cultural differences in nursing homes in three European countries. These findings suggest that structural changes can improve quality of care and quality of life for nursing home residents. Copyright Β© 2009 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
## Abstract The regular use of psychotropic drugs in all patients aged 70 yr and over who were registered at the home nursing centre was studied. 27.4% of the patients used psychotropic drugs, 11.9% used antipsychotics, 14.6% anxiolytics and hypnotics/sedatives and 6% antidepressants. The use of an
## Abstract ## Background Psychiatric and behavioural symptoms in dementia are associated with a range of negative outcomes, including institutional placement and the widespread use of psychotropic drugs in spite of limited evidence for their efficacy. ## Aims To determine the prevalence of psyc
Background The use of psychotropic drugs is high in institutionalised elderly, which raises the question of its appropriateness. This study aimed to: (1) estimate the use of psychotropics, for each family, in terms of the prevalence and dosage among the elderly in nursing homes in French-speaking Sw